Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
FinCanna Capital Surges 38% Despite Minimal Trading Volume
FNNZF stock jumps 38.1% on limited volume of 10,200 shares, highlighting volatility in micro-cap cannabis ancillary space.
Pineapple Express Cannabis Surges 111% Despite Zero Share Price
PNXP stock experiences massive percentage gains on 900K+ volume despite trading near zero, raising questions about market mechanics.
ASX Cannabis Stocks Show Resilience as Medical Market Matures
Australian cannabis companies demonstrate growing stability in medical marijuana sector despite global market volatility affecting North American peers.
Cannabis Companies Face Critical Scale Test as Industry Matures
Global cannabis operators must achieve operational scale to survive intensifying competition and margin pressure in maturing markets.
DEA Rescheduling Hearings Begin as Medical Cannabis Gains Momentum
Federal hearings on marijuana rescheduling commence, driven by expanding medical research and rising patient demand across healthcare sectors.
Texas AG Paxton Escalates Cannabis Opposition Amid Industry Growth
Texas Attorney General intensifies anti-cannabis stance as national legalization momentum builds, creating regulatory headwinds for expanding industry.
Texas AG Paxton Reinforces Anti-Cannabis Stance Amid Reform Momentum
Attorney General Ken Paxton's continued opposition to cannabis reform creates regulatory headwinds for industry expansion in America's second-largest state.
Virginia Delays Cannabis Retail Launch to 2027 Amid Regulatory Hurdles
Virginia pushes back recreational cannabis retail sales by three years, highlighting ongoing challenges in establishing regulated markets across emerging states.
Tilray Expands Digital Health Play with HelloMD Acquisition
Cannabis giant TLRY adds telehealth platform to diversification strategy as sector consolidation accelerates
Cannabis Rescheduling Faces Political Opposition as Federal Hearings Begin
Critics challenge DEA rescheduling process as politically motivated while industry awaits potential regulatory shift that could reshape market dynamics.
Anti-Cannabis Group Challenges DEA Rescheduling Despite Industry Momentum
MMJ opposition group files legal challenge against marijuana rescheduling as cannabis sector awaits regulatory clarity that could unlock institutional investment.
Virginia Delays Cannabis Retail Launch to 2027 in Regulatory Setback
Virginia pushes back recreational cannabis retail sales by three years, highlighting ongoing regulatory challenges facing state-level market development.
Israel Reopens Anti-Dumping Probe Into Canadian Cannabis Imports
Israeli authorities launch new investigation into alleged below-cost pricing by Canadian medical cannabis exporters, threatening market access for major producers.
Virginia Delays Cannabis Retail Until 2027 in Conservative Rollout
Virginia pushes recreational marijuana retail sales to 2027, creating a cautious timeline that may disappoint investors but reflects regulatory realities.
Virginia Sets 2027 Launch Date for Adult-Use Cannabis Retail Sales
Virginia establishes timeline for recreational marijuana retail operations, marking another state's entry into the regulated adult-use market.
Cannabis Retail Margins Under Pressure as Dispensaries Slash Prices
Deep promotional discounts signal intensifying competition and margin compression across cannabis retail sector as operators fight for market share.
Tilray Expands Medical Cannabis Reach Through Strategic Platform Growth
TLRY advances international medical cannabis operations with platform expansion, targeting revenue diversification beyond recreational markets.
Tilray Acquires HelloMD's Canadian Medical Cannabis Operations
Tilray expands its medical cannabis footprint through strategic acquisition of HelloMD's Canadian assets, strengthening its position in the regulated medical market.
Idaho Medical Cannabis Push Continues After Legislative Roadblock
Advocates press forward with ballot initiative despite recent setback in conservative state's legalization efforts.
Cannabis Advocates Challenge DEA Rescheduling Process Integrity
Industry groups question fairness of federal marijuana rescheduling proceedings as regulatory uncertainty weighs on sector valuations.